Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neuromodulation Therapy Device for the Treatment of Sleep Apnea

This study has been completed.
Dymedix Corporation
Information provided by (Responsible Party):
John G. Park, Mayo Clinic Identifier:
First received: February 8, 2010
Last updated: May 26, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)